Results 241 to 250 of about 352,666 (292)
Some of the next articles are maybe not open access.

Disuse Atrophy of Human Skeletal Muscles

Archives of Neurology, 1969
DISUSE ATROPHY is a term frequently and glibly used by clinicians and pathologists alike when faced with a nonspecific muscular atrophy. Unfortunately for both, this is usually a diagnosis of exclusion. Histological changes in cases of pure disuse atrophy in human skeletal muscles are wanting.
A N, Patel, Z A, Razzak, D K, Dastur
openaire   +2 more sources

Intracellular signaling during skeletal muscle atrophy

Muscle & Nerve, 2005
AbstractA variety of conditions lead to skeletal muscle atrophy including muscle inactivity or disuse, multiple disease states (i.e., cachexia), fasting, and age‐associated atrophy (sarcopenia). Given the impact on mobility in the latter conditions, inactivity could contribute in a secondary manner to muscle atrophy.
Susan C, Kandarian, Robert W, Jackman
openaire   +2 more sources

Skeletal Muscle Atrophy in Bioengineered Skeletal Muscle: A New Model System

Tissue Engineering Part A, 2013
Skeletal muscle atrophy has been well characterized in various animal models, and while certain pathways that lead to disuse atrophy and its associated functional deficits have been well studied, available drugs to counteract these deficiencies are limited.
Peter H U, Lee, Herman H, Vandenburgh
openaire   +2 more sources

Skeletal Muscle Atrophy Model

2017
Skeletal muscle atrophy occurs when there is a higher concentration of the transcription factor Forkhead box protein O1 (Foxo-1) inside the nucleus of a skeletal muscle cell than in the cytoplasm. Within a skeletal muscle cell, only dephosphorylated Foxo-1 can enter the nucleus, while only phosphorylated Foxo-1 can exit the nucleus.
Furman, Samantha   +2 more
openaire   +1 more source

Space travel directly induces skeletal muscle atrophy

The FASEB Journal, 1999
ABSTRACT Space travel causes rapid and pronounced skeletal muscle wasting in humans that reduces their long‐term flight capabilities. To develop effective countermeasures, the basis of this atrophy needs to be better understood.
H, Vandenburgh   +4 more
openaire   +2 more sources

ATROPHY IN SKELETAL MUSCLE

JAMA: The Journal of the American Medical Association, 1942
Mammalian skeletal muscle is served by a number of different types of nerve fibers. Some represent the central and others the autonomic nervous system. Diagrammatic representation of the component parts of skeletal muscle innervation has been attempted in figure 1.
openaire   +1 more source

The molecular basis of skeletal muscle atrophy

American Journal of Physiology-Cell Physiology, 2004
Skeletal muscle atrophy attributable to muscular inactivity has significant adverse functional consequences. While the initiating physiological event leading to atrophy seems to be the loss of muscle tension and a good deal of the physiology of muscle atrophy has been characterized, little is known about the triggers or the molecular signaling events ...
Robert W, Jackman, Susan C, Kandarian
openaire   +2 more sources

Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptor

Journal of Cellular Physiology, 2020
Skeletal muscle atrophy is characterized by the degradation of myofibrillar proteins, such as myosin heavy chain or troponin. An increase in the expression of two muscle‐specific E3 ligases, atrogin‐1 and MuRF‐1, and oxidative stress are involved in ...
J. Ábrigo   +10 more
semanticscholar   +1 more source

Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy

Muscle & Nerve, 2005
AbstractSeveral GTP‐binding protein (G‐protein)–coupled receptors that signal through Gαs (GTP‐binding protein α stimulatory) and the cyclic adenosine monophosphate (cAMP) pathway increase skeletal muscle mass. In order to further evaluate the role of the cAMP pathway in the regulation of skeletal muscle mass, we utilized inhibitors of ...
Richard T, Hinkle   +4 more
openaire   +2 more sources

Role of ATF4 in skeletal muscle atrophy

Current Opinion in Clinical Nutrition & Metabolic Care, 2017
Here, we discuss recent work focused on the role of activating transcription factor 4 (ATF4) in skeletal muscle atrophy.Muscle atrophy involves and requires widespread changes in skeletal muscle gene expression; however, the transcriptional regulatory proteins responsible for those changes are not yet well defined. Recent work indicates that some forms
Christopher M, Adams   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy